Oncologic outcomes at 10 years following robotic radical prostatectomy

European Urology

Volumn 67, Issue 6, 2015, Pages 1168-1176

  Diaz, Mireya ^a   Peabody, James O ^a   Kapoor, Victor ^a   Sammon, Jesse ^a   Rogers, Craig G ^a   Stricker, Hans ^a   Lane, Zhaoli ^a   Gupta, Nilesh ^a   Bhandari, Mahendra ^a   Menon, Mani ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cancer control; Postoperative surveillance; Prostate cancer; Prostatectomy; Robotics

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; BIOCHEMICAL RECURRENCE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER CONTROL; CANCER LOCALIZATION; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE SEVERITY; DISEASE SURVEILLANCE; FOLLOW UP; GLEASON SCORE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS FREE SURVIVAL; MIDDLE AGED; ONCOLOGICAL PARAMETERS; ONCOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; ROBOT ASSISTED RADICAL PROSTATECTOMY; SALVAGE THERAPY; TERTIARY HEALTH CARE; TREATMENT OUTCOME; AGED; BLOOD; CANCER GRADING; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; EVALUATION STUDY; MORTALITY; NEOPLASM METASTASIS; PATHOLOGY; PREVENTION AND CONTROL; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; RISK FACTOR; ROBOTIC SURGICAL PROCEDURE; STATISTICS AND NUMERICAL DATA; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; ROBOTIC SURGICAL PROCEDURES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84929030994     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.06.025     Document Type: Article

References (28)

1. M. Menon, A. Shrivastava, and A. Tewari Laparoscopic and robot assisted radical prostatectomy: establishment of a structured program and preliminary analysis of outcomes J Urol 168 2002 945 949
2. M. Menon, A. Tewari, and J. Peabody Vattikuti Institute prostatectomy: technique J Urol 169 2003 2289 2292
3. G. Novara, V. Ficarra, and S. Mocellin Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatecomy Eur Urol 62 2012 382 404
4. M. Menon, A. Bhandari, and G. Nilesh Biochemical recurrence following robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up Eur Urol 58 2010 838 846
5. N. Suardi, V. Ficarra, and P. Villemsen Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: analysis of a single-center series of patients with a minimum follow-up of 5 years Urology 79 2012 133 138
6. P. Sooriakumaran, L. Haendler, and T. Nyberg Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years Eur Urol 62 2012 768 774
7. R. Gillitzer, C. Thuroff, and T. Fandel Intraoperative peripheral frozen sections do not significantly affect prognosis after nerve-sparing radical prostatectomy for prostate cancer BJU Int 107 2010 755 759
8. A.C. Reese, P.M. Pierorazio, M. Han, and A.W. Partin Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system Urology 80 2012 1075 1079
9. R. Savdie, J. Symons, and D. Spernat High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse BJU Int 110 Suppl 4 2012 71 76
10. J. Busch, C. Stephan, and A. Klutzny Impact of positive surgical margins on oncological outcome following laparoscopic radical prostatectomy (LRP): long-term results World J Urol 31 2013 395 401
11. M. Hruza, J.L. Bermejo, and B. Flinspach Long-term oncological outcome after laparoscopic radical prostatectomy BJU Int 111 2013 271 280
12. M. Menon, A. Tewari, B. Baize, B. Guillonneau, and G. Vallancien Prospective comparison of radical retropubic prostatectomy and robot-assisted anatomic prostatectomy: the Vattikuti Urology Institute experience Urology 60 2002 864 868
13. M. Menon, A. Shrivastava, M. Bhandari, R. Satyanarayana, S. Siva, and P.K. Agarwal Vattikuti Institute prostatectomy: technical modifications in 2009 Eur Urol 56 2009 89 96
14. A. Tewari, M. Issa, and R. El-Galley Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study Mol Urol 5 2001 163 169
15. T.A. Stamey, C.M. Yemoto, J.E. McNeal, B.M. Sigal, and I.M. Johnstone Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens J Urol 163 2000 1155 1160
16. M.S. Cookson, G. Aus, and A.L. Burnett Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes J Urol 177 2007 540 545
17. G.S. Gerber, R.A. Thisted, and P.T. Scardino Results of radical prostatectomy in men with clinically localized prostate cancer JAMA 276 1996 615 619
18. A.J. Stephenson, P.T. Scardino, and J.A. Easthman Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 2005 7005 7012
19. D.A. Ahove, K.E. Hoffman, J.C. Hu, T.K. Choueiri, A.V. D'Amico, and P.L. Nguyen Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence? Implications for a risk-adapted follow-up strategy Urology 76 2010 1201 1205
20. M.K. Tollefson, M.L. Blute, L.J. Rangel, J. Karnes, and I. Frank Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy J Urol 184 2010 929 939
21. D.J. Hernández, M.E. Nielsen, and M. Han Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy Urology 72 2008 172 176
22. F.R. Schroeck, M.W. Kattan, and J.W. Moul Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy BJU Int 105 2010 1654 1659
23. A.V. D'Amico, M.-H. Chen, K.A. Roehl, and W.J. Catalona Identifying patients at risk for significant versus clinically insignificant postoperative prostate-specific antigen failure J Clin Oncol 23 2005 4975 4979
24. S. Sukumar, C.G. Rogers, and Q.D. Trinh Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients BJU Int 114 2014 824 831
25. P.C. Walsh, H. Lepor, and J.C. Eggleston Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations Prostate 4 1983 473 485
26. A. Lunacek, C. Schwentner, H. Fritsch, G. Bartsch, and H. Strasser Anatomical radical retropubic prostatectomy: 'curtain dissection' of the neurovascular bundle BJU Int 95 2005 1226 1231
27. M.E. Nielsen, E.M. Schaeffer, P. Marschke, and P.C. Walsh High anterior release of the levator fascia improves sexual function following open radical retropubic prostatectomy J Urol 180 2008 2557 2564 discussion 2564
28. M. Menon, S. Kaul, A. Bhandari, A. Shrivastava, A. Tewari, and A. Hemal Potency following robotic radical prostatectomy: a questionnaire based analysis of outcomes after conventional nerve sparing and prostatic fascia sparing techniques J Urol 174 2005 2291 2296 discussion 2296